Trial intelligence / Profile preview

Lidocaine versus articaine for pain reduction during bilateral mandibular molar implant surgery

IRCT20221227056940N2Phase 3Completed

Sponsor
Golestan University of Medical Sciences
Start
Jul 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, double-blind trial of lidocaine and articaine in edentulism (2 arms), sponsored by Golestan University of Medical Sciences. Primary endpoints: Pain intensity during soft tissue cutting, Pain intensity during bone drilling and 2 more. Started Jul 2025; status: completed.

02

Drugs

lidocainearticaine
03

Conditions

edentulism

Beyond the preview

Go deeper on IRCT20221227056940N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20221227056940N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call